Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Daiken Medical CoTSE:7775 +0.24%62 Days Payable is 30.30 as of Mar. 2026, which is 48% below its 10-year median of 58.29. GuruFocus rates TSE:7775 with a GF Score™ of 62/100 and a GF Value™ of 円541.84 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 794 Medical Devices & Instruments companies, Daiken Medical Co ranks worse than 83.5% on this metric.
The historical rank and industry rank for Daiken Medical Co's Days Payable or its related term are showing as below:
TSE:7775'
s Days Payable Range Over the Past 10 Years
Min: 31.13 Med: 58.29 Max: 78.47
Current: 31.13
During the past 13 years, Daiken Medical Co's highest Days Payable was 78.47. The lowest was 31.13. And the median was 58.29.
TSE:7775's Days Payable is ranked worse than 83.5% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.85
vs TSE:7775: 31.13
Daiken Medical Co's Days Payable
declined
from Mar. 2025 (30.36) to Mar. 2026 (30.30).
It may suggest that Daiken Medical Coaccelerated paying its suppliers.
Daiken Medical Co Days Payable Related Terms
Daiken Medical Co Days Payable Historical Data
* Premium members only.
The historical data trend for Daiken Medical Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7775 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Daiken Medical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daiken Medical Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Daiken Medical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Daiken Medical Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Daiken Medical Co's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daiken Medical Co (TSE:7775) has a Days Payable of 30.30 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Daiken Medical Co and its competitors. This is 48% below median its historical median of 58.29. Over the past decade, Daiken Medical Co's Days Payable has ranged from 31.13 to 78.47. According to the industry distribution chart, Daiken Medical Co ranks #663 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 83.5%.
Is Daiken Medical Co's Days Payable too high?
Daiken Medical Co's current Days Payable of 30.30 is 48% below median its 10-year median of 58.29. Over the past 10 years, this metric has ranged from a low of 31.13 to a high of 78.47. The Medical Devices & Instruments industry median Days Payable is 67.85. Daiken Medical Co's value of 30.30 is 55.3% below this industry median. Based on the distribution chart, Daiken Medical Co ranks #663 out of 794 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Daiken Medical Co has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daiken Medical Co's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Daiken Medical Co ranks #663 out of 794 companies for Days Payable. This places Daiken Medical Co in the lower half of its industry. The industry median Days Payable is 67.85. Daiken Medical Co's value of 30.30 is 55.3% below this benchmark. Historically, Daiken Medical Co's own Days Payable has ranged from 31.13 to 78.47 over the past decade. While the company's 10-year median is 58.29 vs. the industry median of 67.85, Daiken Medical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.85, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daiken Medical Co's current Days Payable of 30.30 is 55.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Daiken Medical Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daiken Medical Co's current Days Payable is 30.30, which is 48% below median its own 10-year median of 58.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Daiken Medical Co (TSE:7775) is currently considered Modestly Undervalued. The stock's GF Value™ is 円541.84, compared to a current price of 円426.00 — trading 21.4% below its estimated fair value. The current Days Payable is 30.30, which is 48% below median its 10-year median of 58.29 and 55.3% below the Medical Devices & Instruments industry median of 67.85. Daiken Medical Co's overall GF Score™ is 62/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Daiken Medical Co (TSE:7775), the current Days Payable is 30.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daiken Medical Co (TSE:7775) Overvalued in 2026?
Based on GuruFocus' analysis, Daiken Medical Co stock appears to be undervalued.
The current stock price of 円426.00 is trading 21.4% below its estimated GF Value™ of 円541.84.
GuruFocus considers Daiken Medical Co to be Modestly Undervalued.
Key valuation signals for TSE:7775:
Days Payable: 30.30 (48% below median its 10-year median of 58.29)
GF Value™: 円541.84 vs. price of 円426.00 (21.4% below fair value)
Industry Position: 55.3% below the Medical Devices & Instruments median (#663 of 794)
No single metric tells the full story. See the TSE:7775 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Daiken Medical Co Ltd manufactures and sells medical equipment. The product line includes - Coopdech syrinjector, Coopdech Syrinjector PCA device, Coopdech Balloonjector, Coopdech Endobronchial blocker tube, Coopdech double-lumen endobronchial tube, Fit fix suction container system, Wet disinfectant mat, and others.
62GF Score
Get the complete analysis for TSE:7775
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7775 has been successfully added to your 
